Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| mast cell | 11 studies | 23% ± 8% | |
| erythrocyte | 10 studies | 41% ± 16% | |
| platelet | 9 studies | 36% ± 7% | |
| renal alpha-intercalated cell | 6 studies | 36% ± 11% | |
| cardiac muscle cell | 5 studies | 30% ± 8% | |
| erythroblast | 4 studies | 43% ± 16% | |
| retinal pigment epithelial cell | 4 studies | 36% ± 20% | |
| ciliated cell | 4 studies | 35% ± 20% | |
| megakaryocyte-erythroid progenitor cell | 4 studies | 45% ± 17% | |
| astrocyte | 4 studies | 37% ± 17% | |
| GABAergic neuron | 3 studies | 19% ± 4% | |
| ependymal cell | 3 studies | 48% ± 15% | |
| megakaryocyte | 3 studies | 57% ± 17% | |
| melanocyte | 3 studies | 29% ± 16% |
Insufficient scRNA-seq data for expression of GMPR at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 96% | 4265.90 | 236 / 245 | 99% | 202.31 | 497 / 502 |
| ovary | 98% | 2674.79 | 177 / 180 | 95% | 89.61 | 407 / 430 |
| adrenal gland | 99% | 1616.21 | 256 / 258 | 51% | 16.88 | 118 / 230 |
| skin | 51% | 468.28 | 927 / 1809 | 83% | 196.75 | 393 / 472 |
| kidney | 98% | 1736.71 | 87 / 89 | 37% | 13.60 | 331 / 901 |
| brain | 64% | 1081.60 | 1682 / 2642 | 69% | 35.79 | 489 / 705 |
| stomach | 94% | 1939.46 | 339 / 359 | 23% | 7.55 | 65 / 286 |
| uterus | 78% | 836.74 | 133 / 170 | 37% | 15.23 | 171 / 459 |
| lung | 76% | 615.36 | 439 / 578 | 30% | 7.56 | 345 / 1155 |
| intestine | 63% | 689.61 | 613 / 966 | 40% | 12.88 | 210 / 527 |
| eye | 0% | 0 | 0 / 0 | 100% | 327.60 | 80 / 80 |
| muscle | 100% | 14727.73 | 803 / 803 | 0% | 0 | 0 / 0 |
| pancreas | 47% | 349.48 | 154 / 328 | 53% | 11.90 | 94 / 178 |
| blood vessel | 98% | 2234.36 | 1310 / 1335 | 0% | 0 | 0 / 0 |
| heart | 96% | 4131.18 | 824 / 861 | 0% | 0 | 0 / 0 |
| spleen | 90% | 856.93 | 218 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 88% | 3012.45 | 817 / 929 | 0% | 0 | 0 / 0 |
| breast | 42% | 340.56 | 192 / 459 | 44% | 14.08 | 491 / 1118 |
| thymus | 19% | 120.66 | 122 / 653 | 53% | 11.35 | 318 / 605 |
| esophagus | 54% | 968.11 | 784 / 1445 | 11% | 2.93 | 21 / 183 |
| bladder | 29% | 204.33 | 6 / 21 | 24% | 7.65 | 120 / 504 |
| adipose | 44% | 392.62 | 526 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 33% | 8.71 | 15 / 45 |
| liver | 6% | 37.45 | 14 / 226 | 18% | 6.53 | 74 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 21% | 4.25 | 6 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006144 | Biological process | purine nucleobase metabolic process |
| GO_0009409 | Biological process | response to cold |
| GO_0006163 | Biological process | purine nucleotide metabolic process |
| GO_1902560 | Cellular component | GMP reductase complex |
| GO_0005829 | Cellular component | cytosol |
| GO_0003920 | Molecular function | GMP reductase activity |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | GMPR |
| Protein name | GMP reductase 1 (GMPR 1) (EC 1.7.1.7) (Guanosine 5'-monophosphate oxidoreductase 1) (Guanosine monophosphate reductase 1) GMP reductase (GMPR) (EC 1.7.1.7) (Guanosine 5'-monophosphate oxidoreductase) (Guanosine monophosphate reductase) |
| Synonyms | GMPR1 |
| Description | FUNCTION: Catalyzes the irreversible NADPH-dependent deamination of GMP to IMP. It functions in the conversion of nucleobase, nucleoside and nucleotide derivatives of G to A nucleotides, and in maintaining the intracellular balance of A and G nucleotides. . FUNCTION: Catalyzes the irreversible NADPH-dependent deamination of GMP to IMP. It functions in the conversion of nucleobase, nucleoside and nucleotide derivatives of G to A nucleotides, and in maintaining the intracellular balance of A and G nucleotides. . |
| Accessions | ENST00000259727.5 P36959 Q7Z527 |